Log In
Print
BCIQ
Print
Print this Print this
 

Marqibo, vincristine

Also known as: Onco TCS

  Manage Alerts
Collapse Summary General Information
Company Arbutus Biopharma Corp.
DescriptionNanoparticle liposomal formulation of vincristine
Molecular Target Tubulin
Mechanism of ActionMicrotubule depolymerization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$217.6M

$11.3M

$195.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today